Dr. Kelsey Klute, MD
Claim this profileUniversity of Nebraska Medical Center
Area of expertise
Pancreatic Cancer
Kelsey Klute, MD has run 5 trials for Pancreatic Cancer. Some of their research focus areas include:
Pancreatic Cyst
Kelsey Klute, MD has run 2 trials for Pancreatic Cyst. Some of their research focus areas include:
Affiliated Hospitals
University Of Nebraska Medical Center
Nebraska Medicine-Nebraska Medical Center
Clinical Trials Kelsey Klute, MD is currently running
Tamoxifen
for Pancreatic Cysts
Pancreatic mucinous cystic neoplasm (MCN) is a precursor to invasive pancreatic adenocarcinoma which occurs almost exclusively in females in their 5th-7th decade. Currently the only option for MCN treatment and prevention of invasive pancreatic ductal adenocarcinoma (PDA) is oncologic resection. The clinical features of pancreatic MCN support the influence of sex hormones in the pathogenesis of the disease. Anti-hormonal therapy may therefore constitute an effective approach to treatment. Preliminary analyses from preclinical studies suggest that tamoxifen inhibits the spread and normal life cycle in MCN epithelial cells and fibroblasts. Investigators hypothesize that in humans, treatment with tamoxifen will lead to cyst regression or stabilization and may spare or delay the need for resection. Up to 15 participants not undergoing immediate resection will be enrolled and take tamoxifen orally for up to 24 weeks. The study will assess the feasibility of tamoxifen as a treatment for pancreatic MCN.
Recruiting
1 award
Phase 1
Early Detection
for Pancreatic Cancer
The purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal adenocarcinoma (PDAC) by establishing a multisite cohort of individuals with family history of PDAC and/or individuals carrying pathogenic/likely pathogenic germline variants (PGVs) in genes linked to PDAC risk for longitudinal follow up.
Recruiting
1 award
N/A
10 criteria
More about Kelsey Klute, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Kelsey Klute, MD has experience with
- Gemcitabine
- Nab-paclitaxel
- Tamoxifen
- None
- Botensilimab
- Heart Rate Monitoring
Breakdown of trials Kelsey Klute, MD has run
Pancreatic Cancer
Pancreatic cystadenoma
Genetic Susceptibility
Genetic Predisposition
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kelsey Klute, MD specialize in?
Kelsey Klute, MD focuses on Pancreatic Cancer and Pancreatic Cyst. In particular, much of their work with Pancreatic Cancer has involved Stage III patients, or patients who are Stage IV.
Is Kelsey Klute, MD currently recruiting for clinical trials?
Yes, Kelsey Klute, MD is currently recruiting for 2 clinical trials in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Kelsey Klute, MD has studied deeply?
Yes, Kelsey Klute, MD has studied treatments such as Gemcitabine, Nab-paclitaxel, Tamoxifen.
What is the best way to schedule an appointment with Kelsey Klute, MD?
Apply for one of the trials that Kelsey Klute, MD is conducting.
What is the office address of Kelsey Klute, MD?
The office of Kelsey Klute, MD is located at: University of Nebraska Medical Center, Omaha, Nebraska 68198 United States. This is the address for their practice at the University of Nebraska Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.